These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
397 related items for PubMed ID: 33182043
1. Didymin ameliorates dexamethasone-induced non-alcoholic fatty liver disease by inhibiting TLR4/NF-κB and PI3K/Akt pathways in C57BL/6J mice. Feng Z, Pang L, Chen S, Pang X, Huang Y, Qiao Q, Wang Y, Vonglorkham S, Huang Q, Lin X, Wei J. Int Immunopharmacol; 2020 Nov; 88():107003. PubMed ID: 33182043 [Abstract] [Full Text] [Related]
2. Corydalis saxicola Bunting Total Alkaloids ameliorate diet-induced non-alcoholic steatohepatitis by regulating hepatic PI3K/Akt and TLR4/NF-κB pathways in mice. Wu J, Chen P, Ju L, Gao R, Li S, Huang Z, Cheng Y, Gui S, Qiu Z, Cheng J, Huang F. Biomed Pharmacother; 2022 Jul; 151():113132. PubMed ID: 35623174 [Abstract] [Full Text] [Related]
4. Integrative Analysis of Transcriptome and Metabolome to Illuminate the Protective Effects of Didymin against Acute Hepatic Injury. Pang L, Xiong Y, Feng Z, Li C, Fang B, Huang Q, Lin X. Mediators Inflamm; 2023 Jul; 2023():6051946. PubMed ID: 36687218 [Abstract] [Full Text] [Related]
10. The protective effect of dexmedetomidine on LPS-induced acute lung injury through the HMGB1-mediated TLR4/NF-κB and PI3K/Akt/mTOR pathways. Meng L, Li L, Lu S, Li K, Su Z, Wang Y, Fan X, Li X, Zhao G. Mol Immunol; 2018 Feb; 94():7-17. PubMed ID: 29241031 [Abstract] [Full Text] [Related]
11. Alleviation of non-alcoholic fatty liver disease by Huazhi Fugan Granules is associated with suppression of TLR4/NF-κB signaling pathway. Ye M, Tang Y, He J, Yang Y, Cao X, Kou S, Wang L, Sheng L, Xue J. Clin Investig Arterioscler; 2021 Feb; 33(5):257-266. PubMed ID: 33810882 [Abstract] [Full Text] [Related]
12. Quercetin ameliorates dysregulation of lipid metabolism genes via the PI3K/AKT pathway in a diet-induced mouse model of nonalcoholic fatty liver disease. Pisonero-Vaquero S, Martínez-Ferreras Á, García-Mediavilla MV, Martínez-Flórez S, Fernández A, Benet M, Olcoz JL, Jover R, González-Gallego J, Sánchez-Campos S. Mol Nutr Food Res; 2015 May; 59(5):879-93. PubMed ID: 25712622 [Abstract] [Full Text] [Related]
13. Liraglutide in combination with human umbilical cord mesenchymal stem cell could improve liver lesions by modulating TLR4/NF-kB inflammatory pathway and oxidative stress in T2DM/NAFLD rats. Xu X, Wang W, Lin L, Chen P. Tissue Cell; 2020 Oct; 66():101382. PubMed ID: 32933722 [Abstract] [Full Text] [Related]
14. Study on the action mechanism of the Polygonum perfoliatum L. on non-alcoholic fatty liver disease, based on network pharmacology and experimental validation. Liu G, Yang L, Tang Y, Lin J, Wang F, Shen J, Chang B, Kong X. J Ethnopharmacol; 2024 Jan 30; 319(Pt 3):117330. PubMed ID: 37863399 [Abstract] [Full Text] [Related]
15. Orientin Modulates Nrf2-ARE, PI3K/Akt, JNK-ERK1/2, and TLR4/NF-kB Pathways to Produce Neuroprotective Benefits in Parkinson's Disease. Vasudevan Sajini D, Thaggikuppe Krishnamurthy P, Chakkittukandiyil A, Mudavath RN. Neurochem Res; 2024 Jun 30; 49(6):1577-1587. PubMed ID: 38276990 [Abstract] [Full Text] [Related]
16. Coactivation of the PI3K/Akt and ERK signaling pathways in PCB153-induced NF-κB activation and caspase inhibition. Liu C, Yang J, Fu W, Qi S, Wang C, Quan C, Yang K. Toxicol Appl Pharmacol; 2014 Jun 15; 277(3):270-8. PubMed ID: 24726520 [Abstract] [Full Text] [Related]
17. Telluric acid ameliorates hepatic ischemia reperfusion-induced injury in rats: Involvement of TLR4, Nrf2, and PI3K/Akt signaling pathways. Rabie MA, Zaki HF, Sayed HM. Biochem Pharmacol; 2019 Oct 15; 168():404-411. PubMed ID: 31386827 [Abstract] [Full Text] [Related]
18. Lupeol protects against cardiac hypertrophy via TLR4-PI3K-Akt-NF-κB pathways. Li D, Guo YY, Cen XF, Qiu HL, Chen S, Zeng XF, Zeng Q, Xu M, Tang QZ. Acta Pharmacol Sin; 2022 Aug 15; 43(8):1989-2002. PubMed ID: 34916609 [Abstract] [Full Text] [Related]
19. Prediction and verification of target of helenalin against hepatic stellate cell activation based on miR-200a-mediated PI3K/Akt and NF-κB pathways. Fang B, Wen S, Li Y, Bai F, Wei Y, Xiong Y, Huang Q, Lin X. Int Immunopharmacol; 2021 Mar 15; 92():107208. PubMed ID: 33444919 [Abstract] [Full Text] [Related]
20. Huangqin decoction mitigates hepatic inflammation in high-fat diet-challenged rats by inhibiting TLR4/NF-κB/NLRP3 pathway. Yan BF, Wang Y, Wang WB, Ding XJ, Wei B, Liu SJ, Fu TM, Chen L, Zhang JZ, Liu J, Zheng X. J Ethnopharmacol; 2023 Mar 01; 303():115999. PubMed ID: 36509260 [Abstract] [Full Text] [Related] Page: [Next] [New Search]